UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 130

Sortiert nach

3-Methyl-3-deazaadenine, a stable isostere of N3-methyl-adenine, is efficiently bypassed by replication in vivo and by transcription in vitro

DNA repair, 2011-08, Vol.10 (8), p.861-868

2011

Volltextzugriff (PDF)

The 4-nitroquinoline 1-oxide mutational spectrum in single stranded DNA is characterized by guanine to pyrimidine transversions

Nucleic acids research, 1992-03, Vol.20 (6), p.1283-1287

1992

Volltextzugriff (PDF)

5-Methylcytosine at HpaII sites in p53 is not hypermutable after UVC irradiation

Mutation research, 1999-12, Vol.431 (1), p.93-103

1999

Volltextzugriff (PDF)

Abstract 2316: Mutations in the p53 gene family reveal conservation of structure-function in the L1 and L3 loops and a response element code for transcriptional specificity

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8_Supplement), p.2316-2316

2013

Volltextzugriff (PDF)

Abstract 2883: Impact of novel CDKN2A/p16INK4a 5’UTR variants predisposing to melanoma on p16 translational regulation

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.2883-2883

2016

Volltextzugriff (PDF)

Abstract 3402: ΔN-p63α and TA-p63α exhibit intrinsic differences in transactivation specificities that depend on distinct features of DNA target sites

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.3402-3402

2014

Volltextzugriff (PDF)

Amifostine (WR2721) restores transcriptional activity of specific p53 mutant proteins in a yeast functional assay

Oncogene, 2001-06, Vol.20 (27), p.3533-3540

2001

Volltextzugriff (PDF)

Analysis of 4-nitroquinoline-1-oxide induced mutations at the hprt locus in mammalian cells: possible involvement of preferential DNA repair

Mutagenesis, 1994-01, Vol.9 (1), p.67-72

1994

Volltextzugriff (PDF)

Analysis of stepwise genetic changes in an AIDS‐related Burkitt's lymphoma

International journal of cancer, 2000-12, Vol.88 (5), p.744-750

2000

Volltextzugriff (PDF)

Antitumor Effects of PRIMA-1 and PRIMA-1 Met (APR246) in Hematological Malignancies: Still a Mutant P53-Dependent Affair?

Cells (Basel, Switzerland), 2021-01, Vol.10 (1)

2021

Volltextzugriff (PDF)

Antitumor Effects of PRIMA-1 and PRIMA-1Met (APR246) in Hematological Malignancies: Still a Mutant P53-Dependent Affair?

Cells (Basel, Switzerland), 2021-01, Vol.10 (1), p.98

2021

Volltextzugriff (PDF)

Assessment of the 4‐factor score: Retrospective analysis of 586 CLL patients receiving ibrutinib. A campus CLL study

American journal of hematology, 2021-05, Vol.96 (5), p.E168-E171

2021

Volltextzugriff (PDF)

Autophagy induced by SAHA affects mutant P53 degradation and cancer cell survival

Bioscience reports, 2019-02, Vol.39 (2)

2019

Volltextzugriff (PDF)

The biological effects of N3-methyladenine

Journal of cellular biochemistry, 2004-02, Vol.91 (2), p.250-257

2004

Volltextzugriff (PDF)

Cancer biomarkers in human atherosclerotic lesions: no evidence of p53 involvement

Cancer epidemiology, biomarkers & prevention, 1995-03, Vol.4 (2), p.111

1995

Volltextzugriff (PDF)

The CDKN 2A/p16 INK 4a 5′ UTR sequence and translational regulation: impact of novel variants predisposing to melanoma

Pigment cell and melanoma research, 2016-03, Vol.29 (2), p.210-221

2016

Volltextzugriff (PDF)

The CDKN2A/p16(INK) (4a) 5'UTR sequence and translational regulation: impact of novel variants predisposing to melanoma

Pigment cell and melanoma research, 2016-03, Vol.29 (2), p.210

2016

Volltextzugriff (PDF)

The CDKN2A/p16INK4a 5′UTR sequence and translational regulation: impact of novel variants predisposing to melanoma

Pigment cell and melanoma research, 2016-03, Vol.29 (2), p.210-221

2016

Volltextzugriff (PDF)

The CDKN2A/p16INK4a 5'UTR sequence and translational regulation: impact of novel variants predisposing to melanoma

Pigment cell and melanoma research, 2016-03, Vol.29 (2), p.210

2016

Volltextzugriff (PDF)

Characterization of the p53 mutants ability to inhibit p73 transactivation using a yeast-based functional assay

Oncogene, 2003-08, Vol.22 (34), p.5252-5260

2003

Volltextzugriff (PDF)

Characterization of the p53 mutants ability to inhibit p73β transactivation using a yeast-based functional assay

Oncogene, 2003-08, Vol.22 (34), p.5252-5260

2003

Volltextzugriff (PDF)

Chromosomal aberrations evaluated by CGH, FISH and GTG-banding in a case of AIDS-related Burkitt's lymphoma

Haematologica (Roma), 2000-03, Vol.85 (3), p.250

2000

Volltextzugriff (PDF)

Comparison of ibrutinib and idelalisib plus rituximab in real‐life relapsed/resistant chronic lymphocytic leukemia cases

European journal of haematology, 2021-04, Vol.106 (4), p.493-499

2021

Volltextzugriff (PDF)

Comparison of the biological effects of MMS and Me-lex, a minor groove methylating agent: Clarifying the role of N3-methyladenine

Mutation research, 2014-01, Vol.759, p.45-51

2014

Volltextzugriff (PDF)

1 – 25 von 130

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(111)
Mit Volltextzugriff
(122)

Publikationsform

Artikel
(130)

Sprache

Englisch
(130)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

Science & Technology
(91)
Life Sciences & Biomedicine
(86)
Humans
(59)
Mutation
(40)
Tumor Suppressor Protein P53 - Genetics
(33)
Biochemistry & Molecular Biology
(31)
Biological And Medical Sciences
(30)
Genetics & Heredity
(29)
Oncology
(29)
Base Sequence
(20)
Molecular Sequence Data
(20)
Tumor Suppressor Protein P53 - Metabolism
(20)
Toxicology
(19)
Animals
(16)
Hematology
(16)
P53
(16)
Saccharomyces Cerevisiae - Genetics
(16)
Cell Biology
(15)
Female
(15)
Fundamental And Applied Biological Sciences. Psychology
(15)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

3-Methyl-3-deazaadenine, a stable isostere of N3-methyl-adenine, is efficiently bypassed by replication in vivo and by transcription in vitro

The 4-nitroquinoline 1-oxide mutational spectrum in single stranded DNA is characterized by guanine to pyrimidine transversions

5-Methylcytosine at HpaII sites in p53 is not hypermutable after UVC irradiation

Abstract 2316: Mutations in the p53 gene family reveal conservation of structure-function in the L1 and L3 loops and a response element code for transcriptional specificity

Abstract 2883: Impact of novel CDKN2A/p16INK4a 5’UTR variants predisposing to melanoma on p16 translational regulation

Abstract 3402: ΔN-p63α and TA-p63α exhibit intrinsic differences in transactivation specificities that depend on distinct features of DNA target sites

Amifostine (WR2721) restores transcriptional activity of specific p53 mutant proteins in a yeast functional assay

Analysis of 4-nitroquinoline-1-oxide induced mutations at the hprt locus in mammalian cells: possible involvement of preferential DNA repair

Analysis of stepwise genetic changes in an AIDS‐related Burkitt's lymphoma

Antitumor Effects of PRIMA-1 and PRIMA-1 Met (APR246) in Hematological Malignancies: Still a Mutant P53-Dependent Affair?

Antitumor Effects of PRIMA-1 and PRIMA-1Met (APR246) in Hematological Malignancies: Still a Mutant P53-Dependent Affair?

Assessment of the 4‐factor score: Retrospective analysis of 586 CLL patients receiving ibrutinib. A campus CLL study

Autophagy induced by SAHA affects mutant P53 degradation and cancer cell survival

The biological effects of N3-methyladenine

Cancer biomarkers in human atherosclerotic lesions: no evidence of p53 involvement

The CDKN 2A/p16 INK 4a 5′ UTR sequence and translational regulation: impact of novel variants predisposing to melanoma

The CDKN2A/p16(INK) (4a) 5'UTR sequence and translational regulation: impact of novel variants predisposing to melanoma

The CDKN2A/p16INK4a 5′UTR sequence and translational regulation: impact of novel variants predisposing to melanoma

The CDKN2A/p16INK4a 5'UTR sequence and translational regulation: impact of novel variants predisposing to melanoma

Characterization of the p53 mutants ability to inhibit p73 transactivation using a yeast-based functional assay

Characterization of the p53 mutants ability to inhibit p73β transactivation using a yeast-based functional assay

Chromosomal aberrations evaluated by CGH, FISH and GTG-banding in a case of AIDS-related Burkitt's lymphoma

Clinical impact of TP53 disruption in chronic lymphocytic leukemia patients treated with ibrutinib: a campus CLL study

Comparison of ibrutinib and idelalisib plus rituximab in real‐life relapsed/resistant chronic lymphocytic leukemia cases

Comparison of the biological effects of MMS and Me-lex, a minor groove methylating agent: Clarifying the role of N3-methyladenine

Suchergebnisse filtern